Integrating Depression Care Into HIV Services for Older People With HIV Using a Stepped Care, Task-Sharing Approach.

Depression is a common but often overlooked comorbidity among older adults living with HIV (PLHIV), particularly in low-resource settings. It negatively impacts health outcomes, adherence to antiretroviral therapy (ART), and overall quality of life. Despite its high prevalence, access to specialized mental health services remains limited due to workforce shortages and structural barriers within healthcare systems. A stepped-care task-sharing approach offers a potentially scalable solution by leveraging non-specialist healthcare workers to deliver evidence-based mental health interventions in a structured, stepwise manner. This study aims to evaluate the effectiveness of this approach in reducing depression among older PLHIV and assess its feasibility for broader implementation in Nigerian health facilities.

Study Objectives:

• Effectiveness Assessment: To determine whether integrating a stepped-care task-sharing approach into routine HIV care is more effective in reducing depression symptoms compared to usual treatment among older PLHIV.
• Implementation Feasibility: To identify facilitators and barriers to the successful adaptation and implementation of this intervention in local HIV facilities.
• Patient Outcomes & Treatment Pathways: To evaluate the impact of the intervention on depression severity using the Patient Health Questionnaire-9 (PHQ-9) and examine how patients progress through different treatment steps based on symptom severity.

Study Design & Methodology:

This is a randomized controlled trial (RCT) comparing a stepped-care task-sharing intervention to usual care in older PLHIV with depressive symptoms.

• Inclusion criteria:

o Older adults (≥50 years) living with HIV who screen positive for depression using PHQ-9.

• Randomization:

o Participants will be randomly assigned to either the intervention arm (stepped-care intervention) or the control arm (treatment as usual).

• Intervention Model:

• The intervention follows a stepped-care framework, where treatment intensity is adjusted based on depression severity at each stage.

Outcome Measures:

• Primary Outcome

o Reduction in depression severity as measured by PHQ-9 at 6 weeks, 3 months, and 6 months.

• Secondary Outcomes

• Acceptability of intervention.
• Barriers and facilitators to implementation (qualitative analysis).
• Changes in quality of life and HIV treatment adherence.

The RE-AIM (Reach, Effectiveness, Adoption, Implementation and Maintenance) framework will be used to evaluate effectiveness and implementation and will be measured using the following endpoints:

• Identify barriers and facilitators in adapting a stepped care task-sharing model for depression care.

End point: Identify barriers and facilitators in adapting a stepped care task-sharing model for depression care. Effectiveness is determined by comparing:

Primary Outcome: Reduction in PHQ-9 scores (depression severity).

Secondary Outcomes:

Adherence to psychosocial intervention sessions and medication.

Secondary objectives:

• To compare the effectiveness of utilizing a stepped care task-sharing (SCT) model to usual treatment depression in older PLHIV in an HIV clinic in Nigeria.

Primary outcome: Rates of reduced depressive symptoms.

Secondary outcomes:

Assessing the rates of reduction in depressive symptoms from baseline to after intervention.

Significance of the Study This trial will provide evidence on the effectiveness and feasibility of integrating depression care within routine HIV services using a stepped-care, task-sharing model in Nigeria.

Inclusion criteria

• Consenting individuals living with HIV
• People living with HIV who are 50 years and above (PLHIV aged ≥50 years)
• Those with a score of ≥10 on the 9-item patient-health questionnaire (PHQ-9).

Exclusion criteria

• • Older PLHIV will be assessed for the imminent risk of suicide and if there is an high risk, participant will be excluded.

• Older PLHIV with severe cognitive impairment or diagnosed dementia that limits their ability to provide informed consent or complete study visits will be excluded.
• Participants with comorbidities that can preclude the use of sertraline should be excluded.